Kessler Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $399K | Buy |
1,586
+21
| +1% | +$4.52K | 0.17% | 60 |
|
|
2026
Q1 | $340K | Buy |
1,565
+188
| +14% | +$41.7K | 0.16% | 65 |
|
|
2025
Q4 | $315K | Sell |
1,377
-61
| -4% | -$13.9K | 0.13% | 73 |
|
|
2025
Q3 | $333K | Hold |
1,438
| – | – | 0.14% | 68 |
|
|
2025
Q2 | $267K | Sell |
1,438
-84
| -6% | -$15.6K | 0.11% | 74 |
|
|
2025
Q1 | $319K | Sell |
1,522
-121
| -7% | -$23.5K | 0.16% | 68 |
|
|
2024
Q4 | $292K | Sell |
1,643
-266
| -14% | -$48.9K | 0.14% | 70 |
|
|
2024
Q3 | $377K | Buy |
+1,909
| New | +$356K | 0.19% | 63 |
|
|
2023
Q2 | – | Sell |
-1,888
| Closed | -$301K | – | 172 |
|
|
2023
Q1 | $301K | Buy |
1,888
+29
| +2% | +$4.43K | 0.2% | 54 |
|
|
2022
Q4 | $300K | Buy |
1,859
+11
| +0.6% | +$1.69K | 0.32% | 40 |
|
|
2022
Q3 | $248K | Buy |
1,848
+63
| +4% | +$9.04K | 0.2% | 48 |
|
|
2022
Q2 | $273K | Sell |
1,785
-441
| -20% | -$67.4K | 0.24% | 44 |
|
|
2022
Q1 | $361K | Sell |
2,226
-14
| -0.6% | -$2.03K | 0.21% | 55 |
|
|
2021
Q4 | $303K | Sell |
2,240
-1,669
| -43% | -$197K | 0.17% | 60 |
|
|
2021
Q3 | $422K | Sell |
3,909
-209
| -5% | -$23.9K | 0.3% | 52 |
|
|
2021
Q2 | $464K | Buy |
4,118
+3,230
| +364% | +$364K | 0.37% | 42 |
|
|
2021
Q1 | $96K | Sell |
888
-23
| -3% | -$2.46K | 0.13% | 41 |
|
|
2020
Q4 | $98K | Hold |
911
| – | – | 0.11% | 46 |
|
|
2020
Q3 | $80K | Hold |
911
| – | – | 0.09% | 50 |
|
|
2020
Q2 | $89K | Buy |
911
+240
| +36% | +$21.1K | 0.11% | 44 |
|
|
2020
Q1 | $51K | Sell |
671
-57
| -8% | -$4.86K | 0.07% | 58 |
|
|
2019
Q4 | $64K | Buy |
728
+27
| +4% | +$2.24K | 0.07% | 68 |
|
|
2019
Q3 | $53K | Buy |
701
+107
| +18% | +$7.34K | 0.06% | 74 |
|
|
2019
Q2 | $43K | Sell |
594
-287
| -33% | -$22.6K | 0.05% | 87 |
|
|
2019
Q1 | $71K | Sell |
881
-82
| -9% | -$6.71K | 0.07% | 70 |
|
|
2018
Q4 | $89K | Sell |
963
-8,498
| -90% | -$747K | 0.12% | 58 |
|
|
2018
Q3 | $895K | Sell |
9,461
-965
| -9% | -$91.5K | 0.92% | 36 |
|
|
2018
Q2 | $966K | Sell |
10,426
-263
| -2% | -$25.7K | 1.16% | 30 |
|
|
2018
Q1 | $1.01M | Sell |
10,689
-1,299
| -11% | -$143K | 1.29% | 30 |
|
|
2017
Q4 | $1.16M | Buy |
11,988
+142
| +1% | +$13.4K | 1.45% | 24 |
|
|
2017
Q3 | $1.05M | Buy |
11,846
+4,195
| +55% | +$319K | 1.35% | 24 |
|
|
2017
Q2 | $555K | Buy |
+7,651
| New | +$514K | 0.7% | 30 |
|
|
2015
Q3 | – | Sell |
-29,074
| Closed | -$1.95M | – | 98 |
|
|
2015
Q2 | $1.95M | Buy |
29,074
+590
| +2% | +$38.5K | 3.12% | 6 |
|
|
2015
Q1 | $1.67M | Buy |
28,484
+1,541
| +6% | +$93.1K | 2.83% | 11 |
|
|
2014
Q4 | $1.76M | Buy |
26,943
+2,804
| +12% | +$177K | 2.88% | 8 |
|
|
2014
Q3 | $1.39M | Buy |
24,139
+23,931
| +11,505% | +$1.33M | 2.45% | 10 |
|
|
2014
Q2 | $12K | Hold |
208
| – | – | 0.02% | 83 |
|
|
2014
Q1 | $11K | Hold |
208
| – | – | 0.02% | 75 |
|
|
2013
Q4 | $11K | Sell |
208
-14,332
| -99% | -$704K | 0.02% | 84 |
|
|
2013
Q3 | $650K | Sell |
14,540
-8,543
| -37% | -$379K | 1.78% | 22 |
|
|
2013
Q2 | $954K | Buy |
+23,083
| New | +$1.01M | 2.78% | 16 |
|
Other funds holding ABBV
Kessler Investment Group's ABBV Position: Q2 2026 in Review
Kessler Investment Group increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $4.52K and bringing the position to 1,586 shares worth $399K. The position accounts for 0.17% of the portfolio, ranked #60.
Kessler Investment Group first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.95M in Q2 2015. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Kessler Investment Group held 1,586 shares of AbbVie worth $399K as of Q2 2026.
- Kessler Investment Group bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
- AbbVie made up 0.17% of Kessler Investment Group's portfolio in Q2 2026, its #60 holding.
- Kessler Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
- Kessler Investment Group's AbbVie position peaked at $1.95M in Q2 2015.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Kessler Investment Group's 13F filing for Q2 2026, filed 13 Jul 2026.